{{Rsnum
|rsid=2380205
|Chromosome=10
|position=5886734
|Orientation=plus
|GMAF=0.3825
|Assembly=GRCh37
|GenomeBuild=37.1
|dbSNPBuild=131
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}
{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 27.4 | 49.6 | 23.0
| HCB | 78.8 | 19.0 | 2.2
| JPT | 81.4 | 18.6 | 0.0
| YRI | 15.0 | 42.2 | 42.9
| ASW | 19.3 | 42.1 | 38.6
| CHB | 78.8 | 19.0 | 2.2
| CHD | 78.9 | 17.4 | 3.7
| GIH | 61.0 | 36.0 | 3.0
| LWK | 23.1 | 40.7 | 36.1
| MEX | 67.2 | 24.1 | 8.6
| MKK | 12.2 | 49.4 | 38.5
| TSI | 33.3 | 48.0 | 18.6
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=20453838
|Trait=Breast cancer
|Title=Genome-wide association study identifies five new breast cancer susceptibility loci
|RiskAllele=C
|Pval=5E-7
|OR=1.06
|ORtxt=[1.02-1.10]
|OA=1
}}

{{PMID Auto
|PMID=22348646
|Title=Common variants at 12p11, 12q24, 9p21, 9q31.2 and in ZNF365 are associated with breast cancer risk for BRCA1 and/or BRCA2 mutation carriers
|OA=1
}}

{{PMID|22198471}} Genetic variants at chromosome 9p21, 10p15 and 10q22 and breast cancer susceptibility in a Chinese population. 
four common SNPs at 9p21(rs1011970 and rs10757278), 10p15 (rs2380205), and 10q22 (rs1250009) in a two-stage case-control study with a total of 1792 breast cancer cases and 1,867 controls. We found that rs1250009 at 10q22 was consistently associated with risk of breast cancer in stage 1 and stage 2, with a per-allele OR of 1.13 (95% CI 1.02-1.25) after two stages combined (P = 0.023). However, no significant associations were observed between the other three SNPs and breast cancer risk. 

{{PMID Auto
|PMID=22461340
|Title=11q13 is a susceptibility locus for hormone receptor positive breast cancer
|OA=1
}}

{{PMID| 22198471}} in Chinese women no significant [[breast cancer]] association at [[rs1011970]], [[rs10757278]] or [[rs2380205]]

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | Illumina Human 1M}}